CURIS INC·4

Jul 8, 8:00 PM ET

KAITIN KENNETH I 4

4 · CURIS INC · Filed Jul 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Curis (CRIS) Director Kenneth I. Kaitin Receives Award of 6,800 Shares

What Happened
Kenneth I. Kaitin, a director of Curis, Inc. (CRIS), was granted a derivative award on July 7, 2026 covering 6,800 shares at an exercise/acquisition price of $5.29 per share, with a reported aggregate value of $35,972. This filing reports a grant/award (derivative), not a sale or an immediate exercise.

Key Details

  • Transaction date: July 7, 2026; Form 4 filed July 9, 2026 (within the typical 2-business-day reporting window).
  • Security: Derivative award (option grant) for 6,800 shares at $5.29 per share; aggregate value $35,972.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: F1 — the option grant vests 100% on July 7, 2027.
  • Filing accession: 0001108205-26-000095; Exhibit index includes a Power of Attorney (Exhibit 24.1).

Context
This was an option grant (award) to a director — a compensation/retention action rather than a market purchase or sale. The award does not represent an immediate sale of stock; the options vest fully one year from the grant date per the footnote.

Insider Transaction Report

Form 4
Period: 2026-07-07
Transactions
  • Award

    Non Qualified Stock Option

    [F1]
    2026-07-07$5.29/sh+6,800$35,9726,800 total
    Exercise: $5.29Exp: 2036-07-06Common Stock (6,800 underlying)
Footnotes (1)
  • [F1]The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027.
Signature
/s/ Diantha Duvall, Attorney-in-fact|2026-07-09

Documents

4 files
  • 4
    wk-form4_1783627943.xmlPrimary

    FORM 4

  • EX-24
  • GRAPHIC
    kaitin_powerofattorneyx2001.jpg
  • GRAPHIC
    kaitin_powerofattorneyx2002.jpg